Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GECOP-MMC: HIPEC with Mitomycin C in Colon Cancer Peritoneal Metastases
NCT05250648Phase 4Recruiting
- Sponsor
- Hospital Universitario de Fuenlabrada
- Start
- Mar 2022
- Primary completion
- Oct 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mitomycin c in colon cancer, sponsored by Hospital Universitario de Fuenlabrada. Started Mar 2022; status: recruiting.
02
Drugs
mitomycin c
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT05250648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05250648.